Guangzhou Baiy reported CNY2.31B in EBITDA for its fiscal quarter ending in March of 2026.





Ebitda Change Date
Aspen Pharmacare ZAR 6.06B 867M Jun/2024
Cipla INR 9.55B 3B Mar/2026
Dr.Reddys Laboratories INR 6.46B 14.43B Mar/2026
Jiangsu Hengrui CNY 2.3B 678.46M Dec/2025
Kalbe Farma IDR 1.3T 18.7B Jun/2025
Richter Gedeon HUF 83.47B 692M Mar/2026
Sh Fosun Pharma CNY 1.57B 128.23M Dec/2025
Sh Pharmaceutical CNY 5.01B 2.41B Jun/2025
Sun Pharmaceuticals INR 39.54B 9.94B Mar/2026
Teva Pharmaceutical Industries USD 1.06B 582M Mar/2026